CN105770403A - Traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and preparation method thereof - Google Patents
Traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and preparation method thereof Download PDFInfo
- Publication number
- CN105770403A CN105770403A CN201610280381.2A CN201610280381A CN105770403A CN 105770403 A CN105770403 A CN 105770403A CN 201610280381 A CN201610280381 A CN 201610280381A CN 105770403 A CN105770403 A CN 105770403A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- oral liquid
- chinese medicine
- medicine oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and a preparation method thereof and belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine oral liquid comprises, by weight, 22-30 parts of Humulus Japonicus, 35-40 parts of Folium Ginkgo, 10-15 parts of Fructus Schisandra chinensis, 10-15 parts of Lily Bulb, 28-34 parts of Radix Astragali, 10-15 parts of Honeysuckle Flowers, 10-20 parts of Chinese Yam, 10-15 parts of Radix Ophiopogonis, 15-20 parts of Bitter Apricot Seed, 15-20 parts of Mongolian Dandelion Herb, 15-20 parts of Heartleaf Houttuymia Herb, 13-22 parts of Radix Geutianae, 15-20 parts of Cortex Phellodendri, 20-30 parts of Radix Glycyrrhiza, 15-22 parts of Gardenia Jasminoides Ellis and 10-15 parts of Cortex Magnoliae Officinalis. The traditional Chinese medicine oral liquid can kill germs, injury to hepatic and renal functions is reduced, meanwhile, treatment effect is improved, curative time of pulmonary tuberculosis can be effectively shortened, human body immunity is improved, capability of resisting to pulmonary tuberculosis is enhanced fundamentally, and recurrence is reduced.
Description
Technical field
The present invention relates to technical field of Chinese medicines, specifically the one auxiliary phthisical Chinese medicine oral liquid of existing western medicine and system thereof
Preparation Method.
Background technology
Tuberculosis is also called consumptive disease and " white pestilence ", is a kind of ancient infectious disease, has just had tuberculosis since the own mankind.?
In history, it was once widely current in the whole world, is once the primary killers of the harm mankind, has seized the life of several hundred million people.Tuberculosis
Disease is the chronic infectious disease caused by mycobacterium tuberculosis infection.Tulase may invade the various organ of Whole Body, but mainly invades lung
Dirty, referred to as pulmonary tuberculosis.Tuberculosis can be fallen ill throughout the year, and the teenager of 15 years old to 35 years old is peak occurred frequently lungy
Age.Incubation period 4~8 weeks.Wherein 80% occur in pulmonary, other positions (neck lymph, meninges, peritoneum, intestinal, skin,
Skeleton) also can secondary infection.Interpersonal respiratory infectious is the major way that primary disease infects.The source of infection is contact discharge of bacteria
Lunger.Tuberculosis is the chronic infectious disease caused by mycobacterium tuberculosis, can invade and many internal organs, and excreter is that it is heavy
The source of infection wanted.Not necessarily fall ill after human infection tulase, when resistance reduces or cell-mediated allergy increases,
It is only possible to cause clinical onset.Tulase belongs to Actinomycetal, the Mycobacterium of mycobacteriaceae, for there being the acidproof of pathogenicity
Bacterium.It is broadly divided into the types such as people, cattle, bird, Mus.There is pathogenic person to be mainly human-like bacterium, the rare infection of cattle type bacterium to people.Lung is tied
Core symptom has closer tuberculosis contact history, and onset can suddenly can be delayed, mostly be low grade fever, night sweat, weak, poor appetite, become thin, female
Property menoxenia etc.;Respiratory symptom has cough, expectoration, spitting of blood, chest pain, the most uncomfortable in chest or dyspnea.Pulmonary
Sign is different and variant according to state of an illness weight, extent of disease, in early days, the tuberculosis of little scope be difficult to find positive sign, pathological changes model
Enclosing wider person's percussion is voiced sound, and vocal fremitus strengthens, the low and wet sound of vesicular breathing sound.Late period, tuberculosis formed fibrosis, local contraction
Pleura is made to subside and mediastinal displacement.Pleuritic rub is had in early days tuberculous pleuritis person, when forming a large amount of hydrothorax, thoracic wall
Full, the turbid reality of percussion, vocal fremitus and respiratory murmur lower or disappear.
Pulmonary tuberculosis is divided into: 1. primary pulmonary tuberculosis: ooze out the dumbbell shaped of pathological changes, lymphangitis and enlargement of hilar lymph nodes in lung
The primary complex changed, child is common, or is showed only as hilus pulumonis and mediastinal lymph node enlargement;2. miliary tuberculosis of lung:
Including acute military tuberculosis of the lung and chronic or subacute hematogenous pulmonary tuberculosis amphitypy;Acute military tuberculosis: two lungs
The shade of the foxtail millet grain size being dispersed in, equal density in the same size, the granular shade of foxtail millet being evenly distributed, it is in progress with stadium, can be mutual
Merge;Chronic or subacute hematogenous pulmonary tuberculosis: two lungs occur that pathological changes not of uniform size, new and old are different, skewness,
Edge blurry or sharp keen tuberosity and rope bar shade.3. secondary type pulmonary tuberculosis: this type includes that pathological changes is based on propagation, infiltration
Pathological changes is multiple change main, that cheese pathological changes is main or cavity is master.Infiltrative pulmonary tuberculosis: x-ray Chang Weiyun is cotton-shaped or strip
Infiltration shade, edge blurry or tuberosity, rope strip pathological changes, large stretch of consolidation or spheroid pathological changes or calcification;Chronic fibro-cavitative is exhaled
Inhale road infection and belong to commonly encountered diseases and frequently-occurring disease, bigger to human health risk.
At present, clinically mainly by western medicine pulmonary tuberculosis, as used the medicine such as rifapentine, Rimactazid, but
These medicines are chemotherapeutic, and while killing tulase, the harm to each internal organs of human body is also very big, especially to Liver and kidney merit
The injury of energy is very big, and after healing, phthisical relapse rate is 50%, and antibiotics treatment is easily developed immunity to drugs, and once produces
Raw Drug resistance, it is more likely that pasting medical help, consequence is hardly imaginable, therefore, finds the therapeutic modality of a kind of relative healths to the mankind
Highly significant.
Summary of the invention
For solving the defect that prior art exists, it is desirable to provide a kind of auxiliary phthisical extract oral of existing western medicine
Liquid and preparation method thereof, solves and relies primarily on the antibiotics phthisical technical problem for the treatment of, reduce antibiotics
Injury to other organ function of tuberculosis patient.
To achieve these goals, the technical scheme is that
A kind of auxiliary treats phthisical Chinese medicine oral liquid, and its effective ingredient includes the raw material of following weight portion: grass 22-30 part,
Folium Ginkgo 35-40 part, Fructus Schisandrae Chinensis 10-15 part, Bulbus Lilii 10-15 part, Radix Astragali 28-34 part, Flos Lonicerae 10-15 part, Rhizoma Dioscoreae 10-20
Part, 10-15 part Radix Ophiopogonis, Semen Armeniacae Amarum 15-20 part, Herba Taraxaci 15-20 part, Herba Houttuyniae 15-20 part, Radix Gentianae 13-22 part,
Cortex Phellodendri 15-20 part, Radix Glycyrrhizae 20-30 part, Fructus Gardeniae 15-22 part, Cortex Magnoliae Officinalis 10-15 part.
The present invention can also have a following additional technical feature:
Preferably, its effective ingredient includes the raw material of following weight portion: grass 26 parts, Folium Ginkgo 38 parts, Fructus Schisandrae Chinensis 12 parts,
Bulbus Lilii 12 parts, the Radix Astragali 30 parts, Flos Lonicerae 12 parts, Rhizoma Dioscoreae 15 parts, Radix Ophiopogonis 13 parts, Semen Armeniacae Amarum 17 parts, Herba Taraxaci 17 parts,
Herba Houttuyniae 17 parts, Radix Gentianae 18 parts, Cortex Phellodendri 17 parts, 25 parts of Radix Glycyrrhizae, Fructus Gardeniae 17 parts, Cortex Magnoliae Officinalis 13 parts.
Preferably, its effective ingredient includes the raw material of following weight portion: grass 22 parts, Folium Ginkgo 40 parts, Fructus Schisandrae Chinensis 10 parts,
Bulbus Lilii 10 parts, the Radix Astragali 34 parts, Flos Lonicerae 10-, Rhizoma Dioscoreae 10 parts, Radix Ophiopogonis 15 parts, Semen Armeniacae Amarum 20 parts, Herba Taraxaci 20 parts,
Herba Houttuyniae 20 parts, Radix Gentianae 22 parts, Cortex Phellodendri 15 parts, 20 parts of Radix Glycyrrhizae, Fructus Gardeniae 15 parts, Cortex Magnoliae Officinalis 10 parts.
Preferably, its effective ingredient includes the raw material of following weight portion: grass 30 parts, Folium Ginkgo 35 parts, Fructus Schisandrae Chinensis 10 parts,
Bulbus Lilii 15 parts, the Radix Astragali 34 parts, Flos Lonicerae 15 parts, Rhizoma Dioscoreae 10 parts, Radix Ophiopogonis 15 parts, Semen Armeniacae Amarum 20 parts, Herba Taraxaci 16 parts,
Herba Houttuyniae 15 parts, Radix Gentianae 13 parts, Cortex Phellodendri 20 parts, 30 parts of Radix Glycyrrhizae, Fructus Gardeniae 22 parts, Cortex Magnoliae Officinalis 15 parts.
The present invention also provides for a kind of preparation method assisting and treating phthisical Chinese medicine oral liquid, follows the steps below:
Step 1: weighing after Fructus Schisandrae Chinensis soaks 1-2 hour by recipe quantity, slow fire decocts 2-3 hour, filters, takes filtrate,
Standby;
Step 2: claim grass, Folium Ginkgo, Bulbus Lilii, the Radix Astragali, Flos Lonicerae, Rhizoma Dioscoreae, Radix Ophiopogonis, Semen Armeniacae Amarum, Pu Gong by recipe quantity
After English, Herba Houttuyniae, Radix Gentianae, Cortex Phellodendri, Radix Glycyrrhizae, Fructus Gardeniae, Cortex Magnoliae Officinalis soak 1-2 hour, add 4-6 times of quality of medical material
Water intense fire decoct to boiling half an hour after, filter, take for the first time filtrate, filtering residue adds the hydrology fire of 3-4 times and decocts to boiling
Latter 10 minutes, filter, take second time filtrate, merge twice filtrate, standby;
Step 3: by step: the filtrate that 1, step 2 obtains merges, and being evaporated to temperature under the conditions of temperature is 50 DEG C is 50 DEG C
Time relative density be the ointment of 1.2-1.3, add oral liquid conventional pharmaceutical adjuvants, make oral liquid according to common process.
Further, the drug quality concentration of described oral liquid is 8-10%.
The usage and dosage of the oral liquid of the present invention is: in lunger 1-14 year, drug level quality is that the oral liquid of 8-10% is every
Day twice, each 5-10ml;More than 15 years old, every day twice, each 10-15ml, share better with Western medicine, when share,
Western medicine consumption halves.Anemia of pregnant woman of the present invention disables, and avoids pungent meat or fish food.
The invention have the benefit that the medicine of the present invention has and preferably kill the effect combining pathogenic bacteria, reducing Liver and kidney merit
Therapeutic effect can be improved while damage, it is possible to effectively shorten phthisical healing time, alleviate patient and be in hospital for a long time and take medicine
Pain hardship, and strengthening body resistance, fundamentally improve phthisical ability of resisting, and reduces recurrence probability;The present invention's
Chinese medicine has to protect the liver and protects splenic function, and formula is reasonable, and spleen be soil, earth generating metal, and gold is lung, it is possible to strengthen pulmonary function;Can be complete
Substitute or part substitutes tradition western medicine antibiotics quasi drugs, it is to avoid the serious consequence brought because of Drug resistance.
The additional aspect of the present invention and advantage will part be given in the following description, and part will become apparent from the description below,
Or recognized by the practice of the present invention.
Detailed description of the invention
Below in conjunction with instantiation, the present invention is described in detail.
Embodiment 1
A. following raw material is prepared:
Grass 260g, Folium Ginkgo 380g, Fructus Schisandrae Chinensis 120g, Bulbus Lilii 120g, Radix Astragali 300g, Flos Lonicerae 120g, Rhizoma Dioscoreae 150g,
Radix Ophiopogonis 130g, Semen Armeniacae Amarum 170g, Herba Taraxaci 170g, Herba Houttuyniae 170g, Radix Gentianae 180g, Cortex Phellodendri 170g, Radix Glycyrrhizae 250g,
Fructus Gardeniae 170g, Cortex Magnoliae Officinalis 130g;
B. following steps are used to prepare oral liquid:
Step 1: weighing after Fructus Schisandrae Chinensis soaks 1 hour by recipe quantity, slow fire decocts 2 hours, filters, takes filtrate, standby
With;
Step 2: claim grass, Folium Ginkgo, Bulbus Lilii, the Radix Astragali, Flos Lonicerae, Rhizoma Dioscoreae, Radix Ophiopogonis, Semen Armeniacae Amarum, Pu Gong by recipe quantity
After English, Herba Houttuyniae, Radix Gentianae, Cortex Phellodendri, Radix Glycyrrhizae, Fructus Gardeniae, Cortex Magnoliae Officinalis soak 1 hour, add the water of 4 times of quality of medical material
Intense fire decocts to boiling half an hour after, filters, and takes filtrate for the first time, and filtering residue adds the hydrology fire of 3 times and decocts to latter 10 points of boiling
Clock, filters, and takes second time filtrate, merges twice filtrate, standby;
: step 3: by step: the filtrate that 1, step 2 obtains merges, and being evaporated to temperature under the conditions of temperature is 50 DEG C is 50 DEG C
Time relative density be the ointment of 1.22, take 10g ointment, add 0.5g sodium alginate, 1.5g xylose, 88g water stir,
Filter, fill, make oral liquid.
Embodiment 2
A. following raw material is prepared:
Grass 220g, Folium Ginkgo 400g, Fructus Schisandrae Chinensis 100g, Bulbus Lilii 100g, Radix Astragali 340g, Flos Lonicerae 10-, Rhizoma Dioscoreae 100g,
Radix Ophiopogonis 150g, Semen Armeniacae Amarum 200g, Herba Taraxaci 200g, Herba Houttuyniae 200g, Radix Gentianae 220g, Cortex Phellodendri 150g, Radix Glycyrrhizae 200g,
Fructus Gardeniae 150g, Cortex Magnoliae Officinalis 100g;
B. following steps are used to prepare oral liquid:
Step 1: weighing after Fructus Schisandrae Chinensis soaks 1 hour by recipe quantity, slow fire decocts 3 hours, filters, takes filtrate, standby
With;
Step 2: claim grass, Folium Ginkgo, Bulbus Lilii, the Radix Astragali, Flos Lonicerae, Rhizoma Dioscoreae, Radix Ophiopogonis, Semen Armeniacae Amarum, Pu Gong by recipe quantity
After English, Herba Houttuyniae, Radix Gentianae, Cortex Phellodendri, Radix Glycyrrhizae, Fructus Gardeniae, Cortex Magnoliae Officinalis soak 2 hours, add the water of 6 times of quality of medical material
Intense fire decocts to boiling half an hour after, filters, and takes filtrate for the first time, and filtering residue adds the hydrology fire of 4 times and decocts to latter 10 points of boiling
Clock, filters, and takes second time filtrate, merges twice filtrate, standby;
: step 3: by step: the filtrate that 1, step 2 obtains merges, and being evaporated to temperature under the conditions of temperature is 50 DEG C is 50 DEG C
Time relative density be the ointment of 1.25, stir, add oral liquid conventional pharmaceutical adjuvants, make oral liquid according to common process.
Embodiment 3
A. following raw material is prepared:
Grass 300g, Folium Ginkgo 350g, Fructus Schisandrae Chinensis 100g, Bulbus Lilii 150g, Radix Astragali 340g, Flos Lonicerae 150g, Rhizoma Dioscoreae 100g,
Radix Ophiopogonis 150g, Semen Armeniacae Amarum 200g, Herba Taraxaci 160g, Herba Houttuyniae 150g, Radix Gentianae 130g, Cortex Phellodendri 200g, Radix Glycyrrhizae 300g,
Fructus Gardeniae 220g, Cortex Magnoliae Officinalis 150g;
B. following steps are used to prepare oral liquid:
Step 1: weighing after Fructus Schisandrae Chinensis soaks 2 hours by recipe quantity, slow fire decocts 2.5 hours, filters, takes filtrate, standby
With;
Step 2: claim grass, Folium Ginkgo, Bulbus Lilii, the Radix Astragali, Flos Lonicerae, Rhizoma Dioscoreae, Radix Ophiopogonis, Semen Armeniacae Amarum, Pu Gong by recipe quantity
After English, Herba Houttuyniae, Radix Gentianae, Cortex Phellodendri, Radix Glycyrrhizae, Fructus Gardeniae, Cortex Magnoliae Officinalis soak 1.5 hours, add 5 times of quality of medical material
Water intense fire decocts to boiling half an hour after, filters, and takes filtrate for the first time, and filtering residue adds the hydrology fire of 4 times and decocts to boiling 10
Minute, filter, take second time filtrate, merge twice filtrate, standby;
: step 3: by step: the filtrate that 1, step 2 obtains merges, and being evaporated to temperature under the conditions of temperature is 50 DEG C is 50 DEG C
Time relative density be the ointment of 1.3, stir, add oral liquid conventional pharmaceutical adjuvants, make oral liquid according to common process.
Embodiment 4 toxicological study
(1) anxious poison test:
The rat oral gavage selecting body weight 200g ± 10g carries out mtd test.Every day, gavage 2ml, gave in one day at twice,
Being equivalent to clinical 70 times (based on 70kg10ml/ days) intending daily dosage of being grown up, in seven days, none death of mice, puts to death mice solution
Cuing open each internal organs of observation and do not find toxic reaction, administration group and control group mice are without any difference.
(2) long term toxication:
For clinical drug safety, according to country's pertinent regulations to new drug research, the rat of application body weight 200g ± 10g, by real
Test medicine and be set as high, medium and low three dosage, respectively 1ml/ days, 0.5ml/ days, 0.25ml/ days.It is 70kg's by body weight
People calculates, for 35 times, 17.5 times and 9 times of people's effective dose with dosage for 10ml/ days;Separately set a blank group, to reality
Test group high, medium and low three continuous gastric infusions of dosage after 100 days, observe physiology every on rat, the impact of biochemical indicator.
Test result indicate that: increase all without affecting to rat continuous oral 100 days, food-intake and body weight on rat by various dose.
Hepatic and renal function is not all found overt toxicity effect.Routine blood test, blood biochemistry, urine biochemistry and bone marrow sheet etc. are showed no obvious shadow
Ring, between each group, compare no significant difference with matched group.
The clinical Composition analyzed of embodiment 5
Test method: respiratory disease hospital and specialty tuberculosis hospital in Qingdao randomly choose 150 example different age group, different journeys
The patient of degree, carries out clinical trial on the basis of not abandoning western medicine, and is leaving hospital and be tracked seeing to it after drug withdrawal
Examine.150 example patients are randomly divided into three groups, and complete Western medicine group combined by Western medicine group and Chinese medicine association part Western medicine group and Chinese medicine,
It is administered as follows: Western medicine group is administered according to traditional antibiotic treatment prescription;Chinese medicine association part Western medicine group is by tradition antibiosis
Every kind of amount of medicament of extract for treating amount halves, coordinate the embodiment of the present invention 1 Chinese medicine oral liquid, 1-14 year patient, every day twice, often
Secondary 5-10ml;More than 15 years old, every day twice, each 10-15ml;Chinese medicine combine complete Western medicine group be conventional antibiotic dose not
Subtracting the Chinese medicine oral liquid coordinating embodiments of the invention 1, therapeutic outcome is shown in Table 1.
Effect judgment criteria:
Recovery from illness: clinical symptom disappearance;Effective: clinical symptoms has alleviated;Invalid: clinical symptoms has no improvement;Cure time
After being CT examination doctor determine can be with the treatment time of drug withdrawal;Effective time is CT examination focus and starts zooming out, and scabs,
Or there is cough with asthma conditions of patients to take a turn for the better.
Table 1 therapeutic effect table
The therapeutic effect being combined complete Western medicine group from table 1, Chinese medicine association part Western medicine group and Chinese medicine is substantially better than Western medicine group,
Can effectively shorten treatment time, make tuberculosis patient rehabilitation as early as possible, reduce state of an illness pain hardship, increase quality of life, and significantly drop
Low relapse rate, significant to the life security of patient.Therefore, the medicine of the present invention can replace to a certain extent
Part Western medicine or with Western medicine therapeutic alliance pulmonary tuberculosis, reduce the reduction immunity that causes of abuse of antibiotics, the problem such as develop immunity to drugs,
Further, finding over the course for the treatment of, Western medicine group is easier to cause the diseases such as liver dysfunction, gastric injury over the course for the treatment of, and one
There is liver function, stomach merit injured patient in denier, then need to stop tuberculosis medicine, and this most also develops immunity to drugs to pathogenic bacteria and adds chance,
And delay healing time.And use treatment by Chinese herbs group not have liver function degree of impairment, therefore, use treatment by Chinese herbs to health
Few side effects, and the formula of the present invention has to protect the liver and protects renal function, has staple market and is worth.
Although an embodiment of the present invention has been shown and described, it will be understood by those skilled in the art that: without departing from this
These embodiments can be carried out multiple change in the case of the principle of invention and objective, revise, replace and modification, the present invention's
Scope is limited by claim and equivalent thereof.
Claims (5)
1. an auxiliary treats phthisical Chinese medicine oral liquid, it is characterized in that, its effective ingredient includes the raw material of following weight portion: grass 22-30 part, Folium Ginkgo 35-40 part, Fructus Schisandrae Chinensis 10-15 part, Bulbus Lilii 10-15 part, Radix Astragali 28-34 part, Flos Lonicerae 10-15 part, Rhizoma Dioscoreae 10-20 part, 10-15 part Radix Ophiopogonis, Semen Armeniacae Amarum 15-20 part, Herba Taraxaci 15-20 part, Herba Houttuyniae 15-20 part, Radix Gentianae 13-22 part, Cortex Phellodendri 15-20 part, Radix Glycyrrhizae 20-30 part, Fructus Gardeniae 15-22 part, Cortex Magnoliae Officinalis 10-15 part.
Auxiliary the most according to claim 1 treats phthisical Chinese medicine oral liquid, it is characterized in that, its effective ingredient includes the raw material of following weight portion: grass 26 parts, Folium Ginkgo 38 parts, Fructus Schisandrae Chinensis 12 parts, Bulbus Lilii 12 parts, the Radix Astragali 30 parts, Flos Lonicerae 12 parts, Rhizoma Dioscoreae 15 parts, Radix Ophiopogonis 13 parts, Semen Armeniacae Amarum 17 parts, Herba Taraxaci 17 parts, Herba Houttuyniae 17 parts, Radix Gentianae 18 parts, Cortex Phellodendri 17 parts, 25 parts of Radix Glycyrrhizae, Fructus Gardeniae 17 parts, Cortex Magnoliae Officinalis 13 parts.
Auxiliary the most according to claim 1 treats phthisical Chinese medicine oral liquid, it is characterized in that, its effective ingredient includes the raw material of following weight portion: grass 22 parts, Folium Ginkgo 40 parts, Fructus Schisandrae Chinensis 10 parts, Bulbus Lilii 10 parts, the Radix Astragali 34 parts, Flos Lonicerae 10-, Rhizoma Dioscoreae 10 parts, Radix Ophiopogonis 15 parts, Semen Armeniacae Amarum 20 parts, Herba Taraxaci 20 parts, Herba Houttuyniae 20 parts, Radix Gentianae 22 parts, Cortex Phellodendri 15 parts, 20 parts of Radix Glycyrrhizae, Fructus Gardeniae 15 parts, Cortex Magnoliae Officinalis 10 parts.
Auxiliary the most according to claim 1 treats phthisical Chinese medicine oral liquid, it is characterized in that, its effective ingredient includes the raw material of following weight portion: grass 30 parts, Folium Ginkgo 35 parts, Fructus Schisandrae Chinensis 10 parts, Bulbus Lilii 15 parts, the Radix Astragali 34 parts, Flos Lonicerae 15 parts, Rhizoma Dioscoreae 10 parts, Radix Ophiopogonis 15 parts, Semen Armeniacae Amarum 20 parts, Herba Taraxaci 16 parts, Herba Houttuyniae 15 parts, Radix Gentianae 13 parts, Cortex Phellodendri 20 parts, 30 parts of Radix Glycyrrhizae, Fructus Gardeniae 22 parts, Cortex Magnoliae Officinalis 15 parts.
5. the auxiliary described in claim 1 treats the preparation method of phthisical Chinese medicine oral liquid, it is characterised in that follow the steps below:
Step 1: weighing after Fructus Schisandrae Chinensis soaks 1-2 hour by recipe quantity, slow fire decocts 2-3 hour, filters, takes filtrate, standby;
Step 2: after claiming grass, Folium Ginkgo, Bulbus Lilii, the Radix Astragali, Flos Lonicerae, Rhizoma Dioscoreae, Radix Ophiopogonis, Semen Armeniacae Amarum, Herba Taraxaci, Herba Houttuyniae, Radix Gentianae, Cortex Phellodendri, Radix Glycyrrhizae, Fructus Gardeniae, Cortex Magnoliae Officinalis to soak 1-2 hour by recipe quantity, the water intense fire adding 4-6 times of quality of medical material decocts to boiling half an hour after, filter, take filtrate for the first time, filtering residue adds the hydrology fire of 3-4 times and decocts to latter 10 minutes of boiling, filters, takes second time filtrate, merge twice filtrate, standby;
Step 3: by step: the filtrate that 1, step 2 obtains merges, and being evaporated to relative density when temperature is 50 DEG C under the conditions of temperature is 50 DEG C is the ointment of 1.2-1.3, adds oral liquid conventional pharmaceutical adjuvants, makes oral liquid according to common process.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610280381.2A CN105770403A (en) | 2016-04-28 | 2016-04-28 | Traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610280381.2A CN105770403A (en) | 2016-04-28 | 2016-04-28 | Traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770403A true CN105770403A (en) | 2016-07-20 |
Family
ID=56400200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610280381.2A Withdrawn CN105770403A (en) | 2016-04-28 | 2016-04-28 | Traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770403A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101954015A (en) * | 2010-08-27 | 2011-01-26 | 孔德旺 | Chinese traditional medicine composition for treating phthisis |
CN103623360A (en) * | 2013-12-17 | 2014-03-12 | 张福娟 | Traditional Chinese medicinal prescription for treating phthisis |
CN104771645A (en) * | 2014-01-17 | 2015-07-15 | 李庆方 | Application of traditional Chinese medicine composition paste for treatment of pulmonary tuberculosis |
-
2016
- 2016-04-28 CN CN201610280381.2A patent/CN105770403A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101954015A (en) * | 2010-08-27 | 2011-01-26 | 孔德旺 | Chinese traditional medicine composition for treating phthisis |
CN103623360A (en) * | 2013-12-17 | 2014-03-12 | 张福娟 | Traditional Chinese medicinal prescription for treating phthisis |
CN104771645A (en) * | 2014-01-17 | 2015-07-15 | 李庆方 | Application of traditional Chinese medicine composition paste for treatment of pulmonary tuberculosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014139255A1 (en) | Pharmaceutical composition for treating cancers and preparation method thereof | |
CN111388582B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof | |
CN103110730B (en) | Perillaseed-radix scutellariae-almond decoction for treating asthma and preparation method thereof | |
WO2021179505A1 (en) | Forsythia suspensa and astragalus membranaceus compound preparation, preparation method therefor and application thereof | |
CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
CN102764371B (en) | Traditional Chinese medicine compound prescription for relieving radiotherapy side reactions and preparation method and application thereof | |
CN108324833A (en) | A kind of Chinese medicine preparation for treating Connective Tissue Disease interstitial lung disease | |
CN107648468A (en) | A kind of Chinese medicine composition for treating COPD and its application | |
CN102772611B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
CN104306793B (en) | A kind of Chinese medicine preparation for treating lobar pneumonia | |
CN105497723A (en) | Traditional Chinese medicine preparation for treating bacterial pneumonia and preparation method thereof | |
CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
CN103655849B (en) | Chinese medicine composition for the treatment of anemofrigid cold and its preparation method and application | |
CN105770403A (en) | Traditional Chinese medicine oral liquid for adjuvant therapy of pulmonary tuberculosis and preparation method thereof | |
CN105816661A (en) | Traditional Chinese medicine oral liquid with liver protecting effect and preparation method thereof | |
CN105327055A (en) | Cudweed combined medicine for treating chronic bronchial asthma | |
CN104721386B (en) | A kind of Traditional Chinese medicine external patch and preparation method thereof for treating asthenic cold type cough and asthma | |
CN102274343B (en) | Medicament for treating avian infectious bronchitis and preparation method thereof | |
CN107823424A (en) | A kind of Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
CN103520414B (en) | Chinese medicament for treating bronchial asthma | |
CN115475195A (en) | Application of pharmaceutical composition in preparation of medicines and health-care products beneficial to prevention of exacerbation of new coronary pneumonia | |
CN102743708A (en) | Cordyceps sinensis and gecko powder for treating emphysema pulmonary heart disease asthma chronic bronchitis | |
CN102784344A (en) | Traditional Chinese medicine preparation for treating pulmonary tuberculosis | |
CN106668605A (en) | Medicine for treating masked depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160720 |